Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-controlled Study With an Open-label Run-in to Assess the Efficacy and Safety of Hydrocodone Bitartrate (HYD) Tablets 20 to 120 mg Once-daily in Subjects With Moderate to Severe Chronic Low Back Pain
Conditions
Interventions
Hydrocodone bitartrate q24h film-coated tablets
Placebo to match hydrocodone bitartrate q24h tablets
Locations
102
United States
Alliance Clinical Research
Birmingham, Alabama, United States
Coastal Clinical Research, Inc.
Mobile, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
Redpoint Research
Phoenix, Arizona, United States
Genova Clinical Research
Tucson, Arizona, United States
Quality of Life Medical & Research Center, LLC
Tucson, Arizona, United States
Start Date
October 1, 2011
Primary Completion Date
September 1, 2013
Completion Date
October 1, 2013
Last Updated
March 10, 2020
NCT06821607
NCT07282925
NCT03836248
NCT07304076
NCT07132762
NCT06419439
Lead Sponsor
Purdue Pharma LP
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions